BA
HALO icon

BlackRock Advisors’s Halozyme HALO Stock Holding History

BlackRock Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-132,800
Closed -$1.05M – 3618
2013
Q2 		$1.05M Buy
+132,800
New +$846K ﹤0.01% 1362

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Advisors's HALO Position: Q4 2016 in Review

BlackRock Advisors increased its Halozyme (HALO) stake by 461% in Q4 2016, buying an estimated $12.5M and bringing the position to 1,390,733 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #733.

BlackRock Advisors first reported a position in HALO in Q2 2013 and has held it in 15 quarters since. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

  • BlackRock Advisors held 1,390,733 shares of Halozyme worth $13.7M as of Q4 2016.
  • BlackRock Advisors bought 1,143,027 Halozyme shares in Q4 2016, an estimated $12.5M.
  • Halozyme made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #733 holding.
  • BlackRock Advisors first reported a position in Halozyme in Q2 2013 and has held it in 15 quarters since.
  • 168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.